AS03-adjuvanted, very-low-dose influenza vaccines induce distinctive immune responses compared to unadjuvanted high-dose vaccines in BALB/c mice
During the 2009-2010 influenza pandemic, an adjuvanted, dose-sparing vaccine was recommended for most Canadians. We hypothesize that differences exist in the responses to AS03-adjuvanted, low antigen (Ag) dose versus unadjuvanted, full-dose vaccines. We investigated the relationship between Ag dose...
Main Authors: | Karen K Yam, Jyotsana eGupta, Kaitlin eWinter, Elizabeth eAllen, Angela eBrewer, Édith eBeaulieu, Corey P Mallett, David S Burt, Brian J Ward |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00207/full |
Similar Items
-
Low hemagglutinin antigen dose influenza vaccines adjuvanted with AS03 alter the long-term immune responses in BALB/c mice
by: Karen K. Yam, et al.
Published: (2017-03-01) -
Recent Approaches for Solid Dose Vaccine Delivery
by: Nishat Jahan, et al.
Published: (2019-10-01) -
Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective
by: Hansen CA, et al.
Published: (2023-11-01) -
Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV)
by: Zhuofan Li, et al.
Published: (2018-08-01) -
Adjuvanted influenza vaccines
by: John S. Tregoning, et al.
Published: (2018-03-01)